Stock Analysis on Net
Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

Common-Size Balance Sheet: Assets 

Abiomed Inc., common-size consolidated balance sheet: assets

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Cash and cash equivalents 7.94 15.57 15.81 11.48 5.46 7.09
Short-term marketable securities 37.40 23.49 20.62 35.16 40.60 34.68
Accounts receivable, net 5.41 6.50 6.96 8.61 8.90 9.82
Inventories, net 5.62 5.42 7.41 7.68 6.38 6.35
Prepaid expenses and other current assets 1.99 1.74 1.48 1.30 1.50 1.46
Current assets 58.35% 52.73% 52.27% 64.23% 62.85% 59.40%
Long-term marketable securities 13.15 17.67 17.08 2.06 4.77 8.57
Property and equipment, net 12.10 13.19 13.56 13.75 14.90 15.95
Goodwill 4.59 5.26 2.63 3.09 4.55 5.64
Other intangibles, net 2.36 2.82 1.23 1.44 2.12 2.63
Deferred tax assets 0.63 0.76 3.56 7.35 9.00 6.31
Investment in Shockwave Medical 3.68 2.59 4.58 5.33 0.00 0.00
Other investments 4.20 4.22 3.18 2.33 0.00 0.00
Operating lease right-of-use assets 0.57 0.41 0.97 0.00 0.00 0.00
Cross-currency swap 0.00 0.00 0.31 0.00 0.00 0.00
Other intangible assets and other assets 0.37 0.36 0.63 0.41 1.80 1.51
Other assets 8.81% 7.57% 9.67% 8.07% 1.80% 1.51%
Long-term assets 41.65% 47.27% 47.73% 35.77% 37.15% 40.60%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

Cash and Cash Equivalents
Showed an initial decline from 7.09% in 2017 to 5.46% in 2018, followed by a significant increase reaching a peak of 15.81% in 2020. This level was largely maintained in 2021 at 15.57% before dropping to 7.94% in 2022. The trend indicates fluctuating liquidity with a peak in 2020 and a reduction thereafter.
Short-term Marketable Securities
Displayed variability with an increase from 34.68% in 2017 to 40.6% in 2018, a decline to 20.62% in 2020, and then a rise again to 37.4% by 2022. This suggests active management of short-term investments with shifts in allocation over the periods.
Accounts Receivable, Net
Gradually decreased from 9.82% in 2017 to 5.41% in 2022, indicating either improved collection efficiency or relatively lower sales on credit terms over time.
Inventories, Net
Maintained a relatively stable range, peaking at 7.68% in 2019, before declining to around 5.62% in 2022. The slight downward trend post-2019 could reflect improved inventory management or shifts in business operations.
Prepaid Expenses and Other Current Assets
Exhibited a modest but consistent increase from 1.46% in 2017 to 1.99% in 2022, indicating a slight growth in prepaid or other current assets over the years.
Current Assets
Fluctuated notably, increasing from 59.4% in 2017 to a high of 64.23% in 2019, then dropping sharply to around 52.27-52.73% in 2020 and 2021, followed by a rebound to 58.35% in 2022. This reflects changing asset composition between current and long-term assets.
Long-term Marketable Securities
Declined from 8.57% in 2017 to 2.06% in 2019, then sharply increased to around 17% in 2020 and 2021, and slightly decreased to 13.15% in 2022. This indicates significant changes in investment strategy regarding long-term securities, particularly from 2019 to 2021.
Property and Equipment, Net
Steadily declined from 15.95% in 2017 to 12.1% in 2022, suggesting either depreciation exceeding new investments or divestment of physical assets.
Goodwill
Decreased from 5.64% in 2017 to 2.63% in 2020, followed by an increase to 5.26% in 2021 and a slight decrease to 4.59% in 2022. This pattern may indicate acquisitions or impairments influencing goodwill values in recent years.
Other Intangibles, Net
Declined from 2.63% in 2017 to 1.23% in 2020, then increased to 2.82% in 2021 before decreasing slightly to 2.36% in 2022. This reflects some fluctuations in intangible asset composition or valuation.
Deferred Tax Assets
Reduced substantially from 6.31% in 2017 to 0.63% in 2022, indicating a significant decline in deferred tax assets over the period, possibly due to tax position changes or utilization of deferred tax credits.
Investment in Shockwave Medical
First appeared at 5.33% in 2019, then declined to 2.59% in 2021, before a modest increase to 3.68% in 2022. This signifies the initiation and subsequent partial reduction and recovery of this investment component.
Other Investments
Commenced reporting at 2.33% in 2019 and showed a gradual increase reaching 4.2% in 2022, reflecting growing exposure to other investment assets.
Operating Lease Right-of-Use Assets
Recorded starting 2020 at 0.97%, sharply declining in 2021 to 0.41%, and slightly rising to 0.57% in 2022. This indicates the recognition of leasing assets with some fluctuation in recent years.
Cross-currency Swap
Reported only in 2020 at 0.31%, absent in other periods, suggesting a temporary derivative asset during that year.
Other Intangible Assets and Other Assets
Declined from 1.51% in 2017 to 0.37% in 2022, indicating a substantial reduction in miscellaneous intangible and other asset categories over time.
Other Assets
Increased markedly from 1.51% in 2017 to 8.81% in 2022, with a peak of 9.67% in 2020, signaling growing non-classified long-term asset holdings or reclassifications.
Long-term Assets
Decreased overall from 40.6% in 2017 to 41.65% in 2022, with a notable rise peaking at 47.73% in 2020 before declining. This suggests shifts between long-term and current asset balances, peaking in 2020.
Total Assets
Remained constant at 100% by definition across all periods, serving as the basis for relative asset proportional analysis.